BioTime News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

06.02.20	Lineage Provides Positive Update on Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration (Businesswire)
03.01.20	Lineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation (Businesswire)
30.12.19	Lineage Provides Update on Patient Enrollment in Phase I/IIa Clinical Study of OpRegen® for the Treatment of Dry Age-Related Macular Degeneration (Businesswire)
24.12.19	Lineage Cell Therapeutics Enters Into Three Separate License Agreements for Certain Intellectual Property and Assets (Businesswire)
19.12.19	Lineage Cell Therapeutics Provides Shareholder Update (Businesswire)
10.12.19	Lineage Cell Therapeutics and AgeX Therapeutics Announce Issuance of U.S. Patent for Method of Generating Induced Pluripotent Stem Cells (Businesswire)
11.09.19	Lineage Cell Therapeutics Conducts Sale of Shares in OncoCyte Corporation (Businesswire)
05.09.19	Lineage Cell Therapeutics to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019 (Businesswire)
04.09.19	Lineage Cell Therapeutics Announces Issuance of U.S. Patent for Method of Treating Spinal Cord Injury With Stem Cell-Derived Oligodendrocyte Progenitor Cells (Businesswire)
03.09.19	Lineage Cell Therapeutics Announces Data From Vision Restoration Program Published in Stem Cells and Development Journal (Businesswire)
26.08.19	Lineage Cell Therapeutics Announces Issuance of U.S. Patent for System for Generating Immunogenic Dendritic Cells (Businesswire)
20.08.19	Lineage Cell Therapeutics to Ring Opening Bell at the New York Stock Exchange on August 21, 2019 (Businesswire)
13.08.19	Lineage Cell Therapeutics Awarded NIH Grant for Innovative Vision Restoration Program (Businesswire)
12.08.19	Lineage Cell Therapeutics Launches New Corporate Brand (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’299.00	2.40 %	K V
Holcim	89.04	1.09 %	K V
Roche Hldg G	266.90	0.95 %	K V
ABB	49.88	0.81 %	K V
Novartis	90.96	0.63 %	K V
Givaudan	3’882.00	-0.54 %	K V
Zurich Insur Gr	547.20	-0.83 %	K V
Alcon	76.34	-1.14 %	K V
Logitech Intl	78.74	-1.43 %	K V
Geberit	505.80	-1.52 %	K V